PESHAWAR: Vice-chancellor Khyber Medical University Prof Dr Ziaul Haq has been appointed executive director of Higher Education Commission (HEC) Islamabad. Prof Ziaul Haq is not only the youngest ...

In global politics 2025 was the year when an old order ended. President Donald Trump demolished decades-old norms and institutions as dramatically as he set about reshaping the White House. His ...

SINGAPORE, October 22, 2025 (EZ Newswire) -- In a landmark move for the digital trade-finance industry, XDC Ventures, opens new tab, the investment arm of the XDC Network, opens new tab, has announced ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Baraka is perhaps the most interesting personality in a crowded Democratic primary to ...

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...

Newark, New Jersey Mayor Ras Baraka was briefly arrested at an ICE detention center. The arrest occurred during an unannounced inspection by members of New Jersey's congressional delegation. Baraka, a ...

The Omnilux Contour Face Mask is a flexible silicone mask that’s equipped with 132 medical-grade lights, which emit light in two wavelengths—one red and another near-infrared. The brand has a very ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...